This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Ronald J. Bolognese, MD; M. Steven Piver, MD; Julian D. Feldman, MD

JAMA. 1967;199(1):42-43.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WE RECENTLY reported the propensity of medroxyprogesterone acetate (Depo-Provera) for causing missed abortion.¹ Subsequent menstrual abnormalities were noted in 15 of 22 such patients, observations also noted by others.^2-4 During our investigation of 58 patients treated with medroxyprogesterone, we uncovered another endocrine abnormality—persistent puerperal galactorrhea. Although other drugs have been associated with this condition, we know of no published report of abnormal lactation associated with medroxyprogresterone. This communication will present five cases in which galactorrhea developed following administration of medroxyprogesterone, as well as the menstrual response in the 36 cases not previously reported.

Methods and Materials

During 1964 and 1965, fifty-seven patients who received medroxyprogesterone for threatened abortion were investigated. The women ranged in age from 21 to 41 years and in parity from 0 to 10. Fifty or 100 mg weekly doses of medroxyprogresterone acetate were initiated during the first trimester in 44 patients and during the . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia. Reprint requests to 807 Spruce St, Philadelphia 19107 (Dr. Bolognese).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?